| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5712b4838bdb16ebbc41121239e165b9 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D249-22 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D249-22 |
| filingDate |
1981-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1983-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a153bcdca977b36620a30a3da50726b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_819d8760853dc442a14590facd9b6306
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_243aa335ef51771ae7aa4519f76141e1 |
| publicationDate |
1983-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-4378360-A |
| titleOfInvention |
6-{3-[4-(Substituted benzyl)-1-piperazinyl]propyloxy}-4,9-dihydro-4,9-dioxo-1H-naphtho[2,3-d-]-v |
| abstract |
Compounds of formula (I): <IMAGE> (I) wherein R is hydrogen, halogen, C1-4 alkyl or C1-4 alkoxy; R1 is hydrogen or C1-6 alkyl; and n is 1 to 6 and pharmaceutically acceptable salts thereof; pharmaceutical compositions containing them; a process for their preparation; and their use in treating allergy. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005033048-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005033048-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110218198-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007219257-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110218198-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7652043-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4769383-A |
| priorityDate |
1980-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |